BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of $0.22, $0.23 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $24.8 million versus the consensus estimate of $24.05 million.

GUIDANCE:

BioLife Solutions sees FY2026 revenue of $112.5-115 million, versus the consensus of $110.8 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.